Industry News

Clariant Posts Robust Growth for Full-Year 2006 / Delivers Improved Performance in Fourth Quarter

Published on 2007-02-20. Author : SpecialChem

MUTTENZ, Switzerland -- Clariant posted a robust rise in sales for the Full Year 2006, with annual organic sales growth of 7% in Swiss francs and 5% in local currency terms. Sales reached CHF 8.100 billion during the period from CHF 7.728 billion a year earlier. Overall, selling prices remained at stable levels, with significant improvements in certain businesses.

Gross margins for the Full Year increased to 30.7% from 30.5% the previous year, despite raw material and energy costs remaining at high levels over the period. Operating income before exceptionals rose 11% to CHF 592 million from CHF 533 million. The operative margin before exceptionals rose to 7.3% from 6.9%. Operating cash flow improved to CHF 284 million from CHF 209 million a year earlier.

Net income from continuing operations, meanwhile, fell to CHF 131 million from CHF 262 million, mainly impacted by a goodwill impairment charge of CHF 100 million in the leather business, as announced in the third quarter. Including discontinued operations, the company reported a net loss of CHF 78 million compared to a net income of CHF 192 million a year earlier.

"We achieved robust top-line growth with stable pricing in 2006. Profitability increased, but we see considerable room for further improvement," said Jan Secher, Clariant's chief executive officer. "We have laid out clear plans to achieve our goal of above average return on invested capital by the end of 2009. Putting these plans in motion, particularly placing a strong emphasis on improving our cash flow will be our priority this year," he said.


Improvements in cash flow and lower interest expenses

EBITDA before exceptionals rose to CHF 855 million from CHF 795 million a year earlier. The EBITDA before exceptionals margin rose to 10.6% from 10.3% in the period, allowing operating cash flow across all operations to rise to CHF 284 million, up from CHF 209 million in 2005. Net working capital, however, also increased due primarily to the implementation of a new supply chain management system in Europe.

Net income from continuing operations fell to CHF 131 million in 2006 from CHF 262 million in 2005, mainly impacted by a goodwill impairment charge of CHF 100 million in the leather business and by the sale of site services in Germany amounting to approximately CHF 43 million, as announced in the company's Third Quarter results.

Solid sales and improved performance in the Fourth Quarter

Sales in the Fourth Quarter rose 3% to CHF 2.010 billion from 1.958 billion a year earlier. Operative income before exceptionals showed a significant improvement in the Fourth Quarter, up to CHF 134 million from CHF 105 million. Selling prices remained stable and material costs increased year-on-year.

Cash flow increased in the Fourth Quarter to CHF 143 million from CHF 14 million a year earlier. Net income from continuing operations amounted to CHF 23 million, up from the CHF 16 million reported in the same period of 2005.


Masterbatches delivers strongest growth

Masterbatches showed the strongest growth over the Full Year. Organic growth rose 8% in local currency terms, fuelled by solid performances in packaging and consumer goods. A marked improvement in pricing continued to more than offset increased raw material costs. The integration of the recently acquired masterbatches business of Ciba is proceeding well.

Growth in Functional Chemicals driven by process and performance chemicals

Functional Chemicals achieved the second-highest growth of all divisions, with a 7% rise in organic growth over the 12-month period. Process Chemicals, as well as Performance Chemicals, showed particularly strong overall growth, and measures taken by the company lifted Detergents in the Second Half. Demand increased in key businesses including Oil Services, Construction Chemicals and Personal Care products. While the division was able to implement price increases during the period, profitability was affected by rising raw material prices and adverse conditions in the agro-chemical market.

Pigments & Additives experiences strong demand across most product lines

The Pigments & Additives Division reported organic growth of 4% for the Full Year, with strong demand across most product lines, notably in Coatings and Plastics and increased demand for innovative flame retardants and wax products. Despite pricing pressure in most businesses, strong operational leverage contributed to overall margin improvements during the year.

Paper lifts Textile, Leather & Paper Chemicals Division

The Textile, Leather & Paper Chemicals Division posted organic growth of 3% for the Full Year. The division benefited from a very strong pick up in sales volumes in the paper business, primarily optical brighteners. After a weak 2005, Leather made progress overall in 2006, with increased sales in South America and Asia, although the business experienced some weakness towards the end of the year. Textiles were stable despite continued challenging market environments in North America and Asia in 2006.

Clariant addresses underperformance in Life Science Chemicals

Given continued deterioration in market conditions, Clariant has taken active steps to address underperformance. In July 2006, the Pharmaceutical Fine Chemicals business, part of the LSC Division, was sold to TowerBrook Capital Partners. The Custom Manufacturing business, adversely affected by overall weak demand from agrochemical customers, has been earmarked for sale. As a first step, the company has announced today the sale of the DMS business to Grillo Werke AG, Germany. The Specialty Intermediates Business, which experienced weaker demand in 2006, has been integrated into the Functional Chemicals Division from January 1st and the LSC Division has ceased to exist. Custom Manufacturing is now reported under "discontinued operations."


Customer requirements driving innovation

Clariant is increasingly tailoring its innovations to better match its customers' needs, reflecting the company's greater front-end focus. In the Functional Chemicals Division, for example, Clariant has developed a superplasticizer that strengthens cement, an ideal feature for ready-made concrete parts of major construction projects. The product has already been used in the construction of the highest motorway bridge in the world, the Millau Viaduct in France, and the world's tallest building, Taipei 101, in Taiwan's capital. With 40% less water the concrete has better durability and improved binding.

In 2006, Clariant spent 2.6% of total sales on R&D while keeping a close eye on the quality of new products and the return on the capital it is investing. In addition, the company will invest a total of CHF 100 million over the next four years in early-stage "incubator" projects, paving the way for new innovations in areas including multi-functional coatings, membrane technology and nano materials. These incubators will run as start-up companies within Clariant Group Technology.

As a first step, the company last year acquired KiON and made an investment in Starfire, both U.S.-based companies. Clariant will also continue with its strategy of creating alliances with start-up firm and universities. The KiON acquisition gives Clariant the ability to offer products such as anti-grafitti coatings. Starfire uses nanotechnology to produce light materials for uses such as ceramic brakes on motorcycles.

"Our innovation capabilities are key to providing the right features and benefits to our customers and to drive our sustainable and profitable growth," Mr. Secher said. "Our clear priority is to maximize pipeline growth."


Asia posts biggest regional increase; Germany drives progress in Europe

Asia led Clariant's growth in 2006 with organic sales rising 7% to CHF 1.870 billion. China remains a key growth market and progress there was especially notable with sales increasing by 20%. India and Turkey also contributed significantly, with double-digit growth rates in both countries.

Year-on-year organic sales in Europe grew by a robust 5% and 6% in Swiss francs to total CHF 3.94 billion. Sales in Germany, which generates a significant proportion of European sales for the company, grew organically above the regional average at 7%, totaling CHF 1.17 billion. Growth in Eastern Europe was above average for the region.

Solid sales in Americas

The Americas achieved solid organic sales growth of 4% to CHF 2.29 billion, with the contribution from Latin America, up by 5%. The U.S. market recorded growth of 3%, which was below the regional average, taking sales there to CHF 1.03 billion. Strong demand for plastics and construction drove solid growth during the first three quarters, however, lower plastics demand, combined with weaker macroeconomic conditions led to a weaker Fourth Quarter.

Stable payout proposed

Clariant's Board of Directors will propose at the Annual General Meeting on April 2, 2007 a payout of CHF 0.25 per share through a reduction of the nominal value of the shares to CHF 4.25, from CHF 4.50. The proposed payout remains unchanged year-on-year, in line with the company's present dividend policy.

The Board of Directors will also propose the election to the board of Dr. Rudolf Wehrli and Dr. Jürg Witmer, both Swiss citizens, for terms of office of four years. Dr. Wehrli, born in 1949, is former CEO of Gurit-Heberlein AG and now Board member of Gurit Holding AG. He is President of the Board of SF Chem and President of the Swiss Society of Chemical Industries SGCI as well as Board member of several other companies. Dr. Witmer, born in 1948, was CEO of Givaudan SA until 2005 and is now President of the Board of Directors. Among others, he is member of the Board of Directors of Syngenta AG.


Building on strength, focusing on execution

In November, Clariant announced the results of its Strategic Review, outlining how it will achieve World-Class Performance by 2010. The company will focus on generating profitable long-term growth and achieving sustained cost leadership in the specialty chemicals industry. Clariant will build on its strengths in colors, surfaces and performance chemicals, focusing its investments strictly according to value-creation criteria.

Value creation will also be achieved by reducing its cost structure, cutting net working capital and strengthening its performance culture. To reach the mid-term goal, the company aims to achieve a Return on Invested Capital (ROIC) above the average of its peers by the end of 2009. This represents an increase of approximately 25% from current levels.
"In 2006 we laid out clearly our long-term goals of reaching a top-quartile ranking among our peers in value creation", Mr. Secher said. "We are now working towards achieving broad, sustainable improvements across the business."


Setting course to deliver ROIC targets

Throughout 2007, the company will take measures to ensure it meets its mid-term ROIC target. The company expects improved sales in local currency terms in 2007 based on expectations of a broadly stable macro-economic environment as well as continued high raw material and energy prices. It anticipates an increase in operating income before exceptionals from continuing operations, with margins remaining stable. The company also expects higher cash flow from operations before exceptional items, as well as an improvement in recurring net income.

"We expect 2007 to be another good year for top-line growth," Mr. Secher said. "We are fully committed to delivering on our medium-term goals, with a clear focus in 2007 on improving cash flow."

Source: Clariant

K flex Coalescents
Back to Top